Skip to content

Influence of LASER therapy and Ultra-violent radiation on the treatment of diabetic foot

Comparison of LASER and Ultra-violent radiation on the treatment of diabetic foot and patients' quality of life

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202001558172073
Enrollment
60
Registered
2020-01-21
Start date
2020-01-10
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Skin and Connective Tissue Diseases

Interventions

UVR EXPERIMENTAL GROUP
Control group

Sponsors

Dr. Abdulsalam Mohammed Yakasai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Provision of signed and dated informed consent form 2)Male or Female 3)Age:18-90 years old at the time of Informed Consent (Adult, Senior) 4)Type 1 or type 2 Diabetes Mellitus 5)Presence of a diabetic foot ulcer located in the ankle area or below that has persisted a minimum of 3 months prior to the screening visit 6) Ulcer grade classified as =3 according to Wagner grading system or IA according to University of Texas Classification of Diabetic Foot Ulcers. 7) Area of ulcer (after debridement) is at least 4 cm2 8) Arterial perfusion: Patients who demonstrate adequate arterial perfusion defined as either: Ankle/brachial index (ABI) above 0.7 or that have documented confirmation of adequate arterial perfusion 9) For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation

Exclusion criteria

Exclusion criteria: 1) Pre-existing conditions - evidence of gangrene on any part of affected limb, active Charcot's foot on the study limb; infection at time of screening, deep vein thrombosis (DVT), active malignancy, being on dialysis, anemia (Hb 12% (uncontrolled hyperglycemia) 10)Pregnant at the time of screening 11) Has any photobiomodulation (low level laser) device at home

Design outcomes

Primary

MeasureTime frame
wound closure

Secondary

MeasureTime frame
quality of life

Countries

Nigeria

Contacts

Public ContactABDULLAHI MOHAMMED MAHMUD

Head ethics committee

bmrec@kshmb.gov.ng+2348054444447

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026